Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen

por Versluijs, A. Birgitta, de Koning, Coco C. H., Lankester, Arjan C., Nierkens, Stefan, Kollen, Wouter J., Bresters, Dorine, Lindemans, Caroline A., Boelens, Jaap Jan, Bierings, Marc
Publicado 2022

Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia

por Goemans, Bianca F., Noort, Sanne, Blink, Marjolein, Wang, Yong-Dong, Peters, Susan T. C. J., van Wouwe, Jacobus P., Kaspers, Gertjan, de Haas, Valerie, Kollen, Wouter J., van der Velden, Vincent H. J., Gruber, Tanja A., Zwaan, Christian M.
Publicado 2021

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients

por Sassen, Sebastiaan D.T., Mathôt, Ron A.A., Pieters, Rob, Kloos, Robin Q.H., de Haas, Valérie, Kaspers, Gertjan J.L., van den Bos, Cor, Tissing, Wim J.E., te Loo, Maroeska, Bierings, Marc B., Kollen, Wouter J.W., Zwaan, Christian M., van der Sluis, Inge M.
Publicado 2017